New Delhi: A Central Drug Authority for India has been planned on the lines of the US Federal Drug Agency, for which technical expertise and inputs have been received from the US FDA, announced Anbumani Ramadoss, union minister for health and family welfare.
It would, however, take about six to seven years to be completely operational. The agency is expected to set up guidelines and standards that will improve the quality of drugs in India.
The minister said that he had already introduced a bill in the Parliament. The Clinical Establishment Act, would apply to both public and private medical establishments and for hospitals and diagnostics, which would put in place standardized procedures for all hospitals, creating a more transparent and accountable medical and health service provider community.